MAM
HRTX icon

Monaco Asset Management’s Heron Therapeutics HRTX Stock Holding History

Monaco Asset Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-858,122
Closed -$687K – 59
2026
Q1 		$687K Sell
858,122
-374,900
-30% -$434K 0.13% 60
2025
Q4 		$1.6M Buy
1,233,022
+230,546
+23% +$285K 0.28% 53
2025
Q3 		$1.26M Sell
1,002,476
-77,524
-7% -$123K 0.08% 58
2025
Q2 		$2.24M Buy
1,080,000
+120,000
+13% +$245K 0.39% 43
2025
Q1 		$2.11M Sell
960,000
-252,743
-21% -$491K 0.43% 30
2024
Q4 		$1.86M Sell
1,212,743
-465,674
-28% -$755K 0.27% 45
2024
Q3 		$3.34M Buy
1,678,417
+165,253
+11% +$395K 0.48% 36
2024
Q2 		$5.3M Sell
1,513,164
-300,000
-17% -$922K 0.84% 19
2024
Q1 		$5.02M Sell
1,813,164
-413,311
-19% -$1.04M 1.5% 19
2023
Q4 		$3.79M Buy
2,226,475
+1,529,567
+219% +$1.68M 1.11% 29
2023
Q3 		$718K Buy
696,908
+291,908
+72% +$415K 0.21% 59
2023
Q2 		$470K Buy
+405,000
New +$722K 0.13% 57

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Monaco Asset Management's HRTX Position: Q2 2026 in Review

Monaco Asset Management sold out of Heron Therapeutics (HRTX) in Q2 2026, closing a stake of 858,122 shares — an estimated $687K sold.

Monaco Asset Management first reported a position in HRTX in Q2 2023 and held it in 12 quarters. The position peaked at $5.3M in Q2 2024. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • Monaco Asset Management reported no remaining Heron Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Monaco Asset Management sold 858,122 Heron Therapeutics shares in Q2 2026, an estimated $687K.
  • Monaco Asset Management first reported a position in Heron Therapeutics in Q2 2023 and held it in 12 quarters.
  • Monaco Asset Management's Heron Therapeutics position peaked at $5.3M in Q2 2024.
  • 163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Monaco Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.